Vitamin D, C-reactive Protein and Insulin Resistance
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Randomized, double blind, placebo-controlled clinical trial of vitamin D supplementation
(cholecalciferol, 4,000 IU/day for 6 months, in 104 postmenopausal women with type 2 diabetes
mellitus.
The objective was to evaluate the effect of vitamin D supplementation on C-reactive protein
(CRP) and insulin resistance in women with type 2 diabetes mellitus (T2DM).
The trial was conducted from March to October 2008 at the Hospital of the Mexican Social
Security in Cuernavaca, Mexico.
Phase:
Phase 3
Details
Lead Sponsor:
Instituto Nacional de Salud Publica, Mexico
Collaborators:
Ellison Medical / International Nutrition Foundation Instituto Mexicano del Seguro Social Tufts University
Treatments:
Cholecalciferol Ergocalciferols Insulin Vitamin D Vitamins